Local* / pathology

Glofitamab Treatment for DLBCL Shows Cost Savings Over Epcoritamab in US Healthcare

Aug 8, 2025

An economic model reveals glofitamab offers DLBCL patient cost savings versus epcoritamab, despite higher adverse event and treatment administration costs.

Recent Posts

Trump Administration Halts Immigration Applications from 19 Countries
Trump administration halts all immigration applications from 19 countries, including complete citizenship processes, following a shooting in DC.
Republicans Oppose Renewed Expansion of Obamacare Subsidies, Says House Speaker
Republican leaders oppose renewing pandemic-era expansion of Obamacare subsidies, claiming they benefit insurers over patients.
Hyundai’s Answer to Slowing EV Sales: More Buyer Options
Following the repeal of the $7,500 federal tax credit for electric vehicles in the US, sales have slowed down. However, automaker Hyundai is not backing down and continues its electrification strategy.
Pittsburgh’s Ultimate Fitness & Nutrition Guide – CBS
Mastering Your Pre and Post-Workout Nutrition with our KISS Fitness Series As a keen fitness enthusiast, understanding the importance of pre and post-workout nutrition is… Read more: Pittsburgh’s Ultimate Fitness & Nutrition Guide – CBS
Diving into the $6 Trillion Private Asset-Backed Finance Market
Learn about the $6 trillion private asset-backed finance (ABF) market, its rapid growth, and the complexities and risks involved.